Latent Tuberculosis Infection (LTBI) remains a heavily debated topic in reproductive medicine. Many couples undergoing fertility treatments encounter positive screening tests. However, understanding the core difference between latent infection and active disease is vital. In this guide, Prof. (Dr.) Abha Majumdar provides an evidence-based analysis regarding LTBI protocols and their relation to infertility.
Latent TB infection is a condition defined by a positive tuberculin skin test or IGRA. However, these patients show no clinical or radiological evidence of active disease. Individuals with latent TB do not exhibit active symptoms. Furthermore, they cannot spread the infection to others.
In these cases, the TB bacteria lie dormant in the body. The immune system has already produced antibodies against them. This is exactly what screening tests detect. Similarly, the BCG vaccination given soon after birth aims to produce an army of antibodies. These antibodies act as a first line of defense to fight fresh bacterial inhalation from the environment.
The prevalence rate of latent tuberculosis in India is exceptionally high. It ranges from 40% to 50% in various populations. This means that over 500 million people have latent tuberculosis in our country at any given time. However, only 5% to 10% of these cases convert into active TB disease during a lifetime. This transition happens mainly when an individual’s immunity drops significantly.
National Guideline Note: The Indian environment carries a heavy load of Mycobacterium tuberculosis. This environmental load comes primarily from open cases of pulmonary tuberculosis. Therefore, the National TB Elimination Program (formerly RNTCP) only recommends treating active tuberculosis. Treating millions of asymptomatic latent cases would create an unsustainable financial and logistic burden.
On the contrary, the prevalence of latent tuberculosis in Western countries is as low as 0.5%. In low-prevalence zones like the United States and Europe, the environment is practically free of this bacteria. Consequently, Western programs treat latent TB aggressively because there is a minimal risk of environmental re-infection.
The clinical dynamics of high-prevalence areas differ drastically from the West. In developed nations, 90% of active TB cases occur due to the reactivation of old, latent infections. Because environmental exposure is scanty, a single course of preventive treatment can successfully achieve an 80-fold reduction in active TB cases within a community.
Conversely, the situation in India presents distinct challenges. In high-prevalence regions, the efficient detection and treatment of active TB must remain the highest medical priority. Therefore, routine treatment of LTBI in India is generally not recommended for the following reasons:
Treatment of LTBI is highly beneficial for individuals with reversible risk factors that suppress general immunity. For instance, prolonged systemic steroid therapy significantly increases the risk of TB reactivation. In such selective scenarios, short-term chemoprophylaxis is clinically indicated.
However, if a patient suffers from a persistent risk factor, such as Type 2 Diabetes Mellitus or Severe Rheumatoid Arthritis, the risk of re-infection remains constant. Therefore, the individual would face the same environmental risks immediately after completing LTBI treatment.
Administering anti-tubercular therapy (ATT) to healthy individuals with no active disease carries severe clinical risks:
In extreme cases, some urban patients develop Total Drug Resistance (TDR). Due to a lack of specialized sanatoriums, these individuals face isolation to prevent spreading untreatable strains. Ultimately, treating healthy individuals with no symptoms moves us closer to a dangerous era where standard antibiotics lose their efficacy entirely.
No. There is no scientific evidence to suggest that a latent tuberculosis infection causes female infertility.
In a latent state, the bacilli are entirely contained by the body’s immune system. As a result, the bacteria cannot actively divide or incite localized tissue damage or immunological reactions. Therefore, latent infection elsewhere in the body does not alter ovarian function, fallopian tube patency, or endometrial receptivity.
An alteration in fertility only occurs if there has been a distinct, prior episode of Active Genital Tuberculosis that caused structural damage to the reproductive tract. For perspective, thousands of women with active pulmonary tuberculosis conceive naturally and receive successful treatment during pregnancy without any prior history of fertility struggles.
Medically Reviewed & Approved By: Prof. (Dr.) Abha Majumdar, Director & Head of the Centre of IVF, Sir Ganga Ram Hospital, New Delhi. Expert Academic Panelist for International Fertility Forums including ESHRE, IFFS, IFS, and ISAR.
